# The Effects of Sufentanil vs. Remifentanil in Total Intravenous Anesthesia With Remimazolam on Postoperative Pain

> **NCT05785234** · NA · UNKNOWN · sponsor: **Yonsei University** · enrollment: 66 (estimated)

## Conditions studied

- Stomach Neoplasms

## Interventions

- **DRUG:** sufentanil-remimazolam group
- **DRUG:** remifentanil-remimazolam group

## Key facts

- **NCT ID:** NCT05785234
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04
- **Primary completion:** 2025-03
- **Final completion:** 2025-06
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2023-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05785234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05785234, "The Effects of Sufentanil vs. Remifentanil in Total Intravenous Anesthesia With Remimazolam on Postoperative Pain". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05785234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
